Ozempic is not just a weight-loss story anymore
The US adult obesity rate fell to 36.4 percent in 2026, down from a peak of 39.9 percent in 2022, according to a Gallup report, while the share of adults taking GLP-1 drugs for weight loss rose from 3…
The US adult obesity rate fell to 36.4 percent in 2026, down from a peak of 39.9 percent in 2022, according to a Gallup report, while the share of adults taking GLP-1 drugs for weight loss rose from 3…
The FDA approved mFLUSIVA, the first mRNA influenza vaccine licensed in the United States, on August 5, 2026, exactly one year after the Department of Health and Human Services canceled 22 mRNA vaccin…
The July issue of The Highlight explores the loss of tactile experiences in a screen-dominated world, with Sara Herschander reporting on the impact on young children and the potential for a return to …
On June 1, a team of scientists published a preprint claiming they had edited human embryonic DNA with unprecedented precision, a breakthrough that could eventually enable "designer babies" engineered…